How should I use Yervoyg(Ipilimumab)?

The document details precise dosing regimens for YERVOY (ipilimumab) across multiple indications, emphasizing weight-based and combination protocols.

Standardized Dosage Strategies for YERVOY in Oncology

YERVOY is administered intravenously, with dosage and frequency tailored to the specific malignancy and patient characteristics. For unresectable or metastatic melanoma, the recommended dose is 3 mg/kg every 3 weeks for up to 4 doses, either as monotherapy or in combination with nivolumab. 

In renal cell carcinoma and certain colorectal cancers, combination regimens with nivolumab are specified, with YERVOY dosed at 1 mg/kg or 3 mg/kg depending on the indication. Pediatric dosing is weight-adjusted. Administration requires dilution and infusion over 30 minutes, with strict adherence to preparation and administration protocols.